Chimerix, Inc. to Present at JMP Securities Healthcare Conference

Published: Jul 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., July 2, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that M. Michelle Berrey, MD, MPH, Chimerix's Chief Medical Officer, will provide an update on the progress of Chimerix's CMX001 development program at the 8th Annual JMP Securities Healthcare Conference. Dr. Berrey is scheduled to present at 11:30 am ET on Wednesday, July 10, 2013, in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news